These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14599482)

  • 41. Ultrastructural and behavioural changes precede amyloid deposition in a transgenic model of Alzheimer's disease.
    Richardson JC; Kendal CE; Anderson R; Priest F; Gower E; Soden P; Gray R; Topps S; Howlett DR; Lavender D; Clarke NJ; Barnes JC; Haworth R; Stewart MG; Rupniak HT
    Neuroscience; 2003; 122(1):213-28. PubMed ID: 14596862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.
    Schliebs R
    Neurochem Res; 2005; 30(6-7):895-908. PubMed ID: 16187224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain.
    Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R
    Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
    Snellman A; López-Picón FR; Rokka J; Salmona M; Forloni G; Scheinin M; Solin O; Rinne JO; Haaparanta-Solin M
    J Nucl Med; 2013 Aug; 54(8):1434-41. PubMed ID: 23833271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology.
    Apelt J; Schliebs R
    Brain Res; 2001 Mar; 894(1):21-30. PubMed ID: 11245811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Region- and age-specific changes in glutamate transport in the AβPP23 mouse model for Alzheimer's disease.
    Schallier A; Smolders I; Van Dam D; Loyens E; De Deyn PP; Michotte A; Michotte Y; Massie A
    J Alzheimers Dis; 2011; 24(2):287-300. PubMed ID: 21297271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of wild-type and mutant human amyloid precursor protein on cortical afferent network.
    Alpár A; Ueberham U; Seeger G; Arendt T; Gärtner U
    Neuroreport; 2007 Aug; 18(12):1247-50. PubMed ID: 17632276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cholinergic Mechanisms in the Cerebral Cortex: Beyond Synaptic Transmission.
    Ovsepian SV; O'Leary VB; Zaborszky L
    Neuroscientist; 2016 Jun; 22(3):238-51. PubMed ID: 26002948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
    Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interactions between Aβ oligomers and presynaptic cholinergic signaling: age-dependent effects on attentional capacities.
    Parikh V; Bernard CS; Naughton SX; Yegla B
    Behav Brain Res; 2014 Nov; 274():30-42. PubMed ID: 25101540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    Reale M; D'Angelo C; Costantini E; Di Nicola M; Yarla NS; Kamal MA; Salvador N; Perry G
    J Alzheimers Dis; 2018; 62(1):467-476. PubMed ID: 29439355
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early cortical thickness changes predict β-amyloid deposition in a mouse model of Alzheimer's disease.
    Grand'maison M; Zehntner SP; Ho MK; Hébert F; Wood A; Carbonell F; Zijdenbos AP; Hamel E; Bedell BJ
    Neurobiol Dis; 2013 Jun; 54():59-67. PubMed ID: 23454197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired rapid eye movement sleep in the Tg2576 APP murine model of Alzheimer's disease with injury to pedunculopontine cholinergic neurons.
    Zhang B; Veasey SC; Wood MA; Leng LZ; Kaminski C; Leight S; Abel T; Lee VM; Trojanowski JQ
    Am J Pathol; 2005 Nov; 167(5):1361-9. PubMed ID: 16251420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of beta-secretase mRNA in transgenic Tg2576 mouse brain with Alzheimer plaque pathology.
    Bigl M; Apelt J; Luschekina EA; Lange-Dohna C; Rossner S; Schliebs R
    Neurosci Lett; 2000 Oct; 292(2):107-10. PubMed ID: 10998560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of diets containing curcumin, epigallocatechin-3-gallate, docosahexaenoic acid and α-lipoic acid on amyloid load and inflammation in a male transgenic mouse model of Alzheimer's disease: Are combinations more effective?
    Sharman MJ; Gyengesi E; Liang H; Chatterjee P; Karl T; Li QX; Wenk MR; Halliwell B; Martins RN; Münch G
    Neurobiol Dis; 2019 Apr; 124():505-519. PubMed ID: 30610916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ibotenic acid lesion of nucleus basalis magnocellularis differentially affects cholinergic, glutamatergic and GABAergic markers in cortical rat brain regions.
    Rossner S; Schliebs R; Bigl V
    Brain Res; 1994 Dec; 668(1-2):85-99. PubMed ID: 7704621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
    Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
    J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.